# X4 Pharmaceuticals Inc. (XFOR) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$87M |
| 2024 | -$36M |
| 2023 | -$108M |
| 2022 | -$88M |
| 2021 | -$85M |
| 2020 | -$60M |
| 2019 | -$52M |
| 2018 | -$29M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$20M |
| 2025-09-30 | -$28M |
| 2025-06-30 | -$26M |
| 2025-03-31 | -$9M |
| 2024-09-30 | -$35M |
| 2024-06-30 | $71M |
| 2024-03-31 | -$37M |
| 2023-09-30 | -$27M |
| 2023-06-30 | -$26M |
| 2021-09-30 | -$19M |
| 2021-06-30 | -$19M |
| 2021-03-31 | -$18M |
| 2020-09-30 | -$17M |
| 2020-06-30 | -$15M |
| 2020-03-31 | -$11M |
| 2019-09-30 | -$17M |
| 2019-06-30 | -$13M |
| 2019-03-31 | -$10M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/XFOR/operating-income)